Wendy Barclay

Wendy Barclay in 2019 Wendy Sue Fox (née Barclay) is a British virologist. She is currently head of Department of Infectious Disease and chair in Influenza Virology at Imperial College London. She leads a team of scientists studying the influenza virus and its physiology and morphology to discover novel vaccines. In particular, they are trying to understand more about influenza virus mutations, and how they can allow scientists to create new vaccines against possible flu pandemics. Provided by Wikipedia
Showing 1 - 20 results of 23 for search 'Wendy Barclay', query time: 0.08s Refine Results
  1. 1
    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [v2; ref status: indexed, http://f1000r.es/52g]

    Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry [v2; ref status: indexed, http://f1000r.es/52g] by Jason Long, Edward Wright, Eleonora Molesti, Nigel Temperton, Wendy Barclay

    Published 2015-02-01
    Get full text
    Article
  2. 2
    Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England

    Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England by Matthew Whitaker, Joshua Elliott, Barbara Bodinier, Wendy Barclay, Helen Ward, Graham Cooke, Christl A. Donnelly, Marc Chadeau-Hyam, Paul Elliott

    Published 2022-11-01
    Get full text
    Article
  3. 3
    REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol [version 2; peer review: 2 approved]

    REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol [version 2; peer review: 2 approved] by Steven Riley, Christina Atchison, Deborah Ashby, Christl A. Donnelly, Wendy Barclay, Graham S. Cooke, Helen Ward, Ara Darzi, Paul Elliott, REACT study group

    Published 2021-04-01
    Get full text
    Article
  4. 4
    SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people

    SARS-CoV-2 rapid antibody test results and subsequent risk of hospitalisation and death in 361,801 people by Matthew Whitaker, Bethan Davies, Christina Atchison, Wendy Barclay, Deborah Ashby, Ara Darzi, Steven Riley, Graham Cooke, Christl A. Donnelly, Marc Chadeau-Hyam, Paul Elliott, Helen Ward

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.

    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England. by Oliver Eales, David Haw, Haowei Wang, Christina Atchison, Deborah Ashby, Graham S Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Christl A Donnelly, Marc Chadeau-Hyam, Paul Elliott, Steven Riley

    Published 2023-05-01
    Get full text
    Article
  6. 6
    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England

    Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England by Oliver Eales, David Haw, Haowei Wang, Christina Atchison, Deborah Ashby, Graham S. Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Christl A. Donnelly, Marc Chadeau-Hyam, Paul Elliott, Steven Riley

    Published 2023-05-01
    Get full text
    Article
  7. 7
    Species specific differences in use of ANP32 proteins by influenza A virus

    Species specific differences in use of ANP32 proteins by influenza A virus by Jason S Long, Alewo Idoko-Akoh, Bhakti Mistry, Daniel Goldhill, Ecco Staller, Jocelyn Schreyer, Craig Ross, Steve Goodbourn, Holly Shelton, Michael A Skinner, Helen Sang, Michael J McGrew, Wendy Barclay

    Published 2019-06-01
    Get full text
    Article
  8. 8
    Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number

    Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction number by Oliver Eales, Kylie E.C. Ainslie, Caroline E. Walters, Haowei Wang, Christina Atchison, Deborah Ashby, Christl A. Donnelly, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Paul Elliott, Steven Riley

    Published 2022-09-01
    Get full text
    Article
  9. 9
    Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021.

    Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021. by Oliver Eales, Haowei Wang, David Haw, Kylie E C Ainslie, Caroline E Walters, Christina Atchison, Graham Cooke, Wendy Barclay, Helen Ward, Ara Darzi, Deborah Ashby, Christl A Donnelly, Paul Elliott, Steven Riley

    Published 2022-11-01
    Get full text
    Article
  10. 10
    Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults

    Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults by Helen Ward, Graham S. Cooke, Christina Atchison, Matthew Whitaker, Joshua Elliott, Maya Moshe, Jonathan C Brown, Barnaby Flower, Anna Daunt, Kylie Ainslie, Deborah Ashby, Christl A. Donnelly, Steven Riley, Ara Darzi, Wendy Barclay, Paul Elliott

    Published 2021-05-01
    Get full text
    Article
  11. 11
    RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.

    RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals. by Markus Lesch, Madlen Luckner, Michael Meyer, Friderike Weege, Isabella Gravenstein, Martin Raftery, Christian Sieben, Laura Martin-Sancho, Aki Imai-Matsushima, Robert-William Welke, Rebecca Frise, Wendy Barclay, Günther Schönrich, Andreas Herrmann, Thomas F Meyer, Alexander Karlas

    Published 2019-03-01
    Get full text
    Article
  12. 12
    Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodies

    Machine learning to support visual auditing of home-based lateral flow immunoassay self-test results for SARS-CoV-2 antibodies by Nathan C. K. Wong, Sepehr Meshkinfamfard, Valérian Turbé, Matthew Whitaker, Maya Moshe, Alessia Bardanzellu, Tianhong Dai, Eduardo Pignatelli, Wendy Barclay, Ara Darzi, Paul Elliott, Helen Ward, Reiko J. Tanaka, Graham S. Cooke, Rachel A. McKendry, Christina J. Atchison, Anil A. Bharath

    Published 2022-07-01
    Get full text
    Article
  13. 13
    Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England

    Dynamics of competing SARS-CoV-2 variants during the Omicron epidemic in England by Oliver Eales, Leonardo de Oliveira Martins, Andrew J. Page, Haowei Wang, Barbara Bodinier, David Tang, David Haw, Jakob Jonnerby, Christina Atchison, Deborah Ashby, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara Darzi, Steven Riley, Paul Elliott, Christl A. Donnelly, Marc Chadeau-Hyam

    Published 2022-07-01
    Get full text
    Article
  14. 14
    Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study

    Breakthrough SARS-CoV-2 infections in double and triple vaccinated adults and single dose vaccine effectiveness among children in Autumn 2021 in England: REACT-1 study by Marc Chadeau-Hyam, Oliver Eales, Barbara Bodinier, Haowei Wang, David Haw, Matthew Whitaker, Joshua Elliott, Caroline E. Walters, Jakob Jonnerby, Christina Atchison, Peter J. Diggle, Andrew J. Page, Deborah Ashby, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara Darzi, Christl A. Donnelly, Paul Elliott

    Published 2022-06-01
    Get full text
    Article
  15. 15
    Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys

    Omicron SARS-CoV-2 epidemic in England during February 2022: A series of cross-sectional community surveys by Marc Chadeau-Hyam, David Tang, Oliver Eales, Barbara Bodinier, Haowei Wang, Jakob Jonnerby, Matthew Whitaker, Joshua Elliott, David Haw, Caroline E. Walters, Christina Atchison, Peter J. Diggle, Andrew J. Page, Deborah Ashby, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara Darzi, Christl A. Donnelly, Paul Elliott

    Published 2022-10-01
    Get full text
    Article
  16. 16
    SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2

    SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2 by Oliver Eales, Andrew J. Page, Leonardo de Oliveira Martins, Haowei Wang, Barbara Bodinier, David Haw, Jakob Jonnerby, Christina Atchison, The COVID-19 Genomics UK (COG-UK) Consortium, Deborah Ashby, Wendy Barclay, Graham Taylor, Graham Cooke, Helen Ward, Ara Darzi, Steven Riley, Marc Chadeau-Hyam, Christl A. Donnelly, Paul Elliott

    Published 2022-07-01
    Get full text
    Article
  17. 17
    Viral factors in influenza pandemic risk assessment

    Viral factors in influenza pandemic risk assessment by Marc Lipsitch, Wendy Barclay, Rahul Raman, Charles J Russell, Jessica A Belser, Sarah Cobey, Peter M Kasson, James O Lloyd-Smith, Sebastian Maurer-Stroh, Steven Riley, Catherine AA Beauchemin, Trevor Bedford, Thomas C Friedrich, Andreas Handel, Sander Herfst, Pablo R Murcia, Benjamin Roche, Claus O Wilke, Colin A Russell

    Published 2016-11-01
    Get full text
    Article
  18. 18
    Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England

    Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England by Paul Elliott, Oliver Eales, Barbara Bodinier, David Tang, Haowei Wang, Jakob Jonnerby, David Haw, Joshua Elliott, Matthew Whitaker, Caroline E. Walters, Christina Atchison, Peter J. Diggle, Andrew J. Page, Alexander J. Trotter, Deborah Ashby, Wendy Barclay, Graham Taylor, Helen Ward, Ara Darzi, Graham S. Cooke, Marc Chadeau-Hyam, Christl A. Donnelly

    Published 2022-08-01
    Get full text
    Article
  19. 19
    Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise

    Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise by Jessica A. Belser, Eric H. Y. Lau, Wendy Barclay, Ian G. Barr, Hualan Chen, Ron A. M. Fouchier, Masato Hatta, Sander Herfst, Yoshihiro Kawaoka, Seema S. Lakdawala, Leo Yi Yang Lee, Gabriele Neumann, Malik Peiris, Daniel R. Perez, Charles Russell, Kanta Subbarao, Troy C. Sutton, Richard J. Webby, Huanliang Yang, Hui-Ling Yen

    Published 2022-08-01
    Get full text
    Article
  20. 20
    Antiviral Screening of Multiple Compounds against Ebola Virus

    Antiviral Screening of Multiple Compounds against Ebola Virus by Stuart D. Dowall, Kevin Bewley, Robert J. Watson, Seshadri S. Vasan, Chandradhish Ghosh, Mohini M. Konai, Gro Gausdal, James B. Lorens, Jason Long, Wendy Barclay, Isabel Garcia-Dorival, Julian Hiscox, Andrew Bosworth, Irene Taylor, Linda Easterbrook, James Pitman, Sian Summers, Jenny Chan-Pensley, Simon Funnell, Julia Vipond, Sue Charlton, Jayanta Haldar, Roger Hewson, Miles W. Carroll

    Published 2016-10-01
    Get full text
    Article

Search Tools: